Breaking News Instant updates and real-time market news.

IIVI

II-VI

$69.27 /

+1.73 (+2.56%)

08:24
06/07/21
06/07
08:24
06/07/21
08:24

II-VI to demonstrate 400/800G transceivers for datacenter switchs

II-VI Incorporated announced that it will be virtually demonstrating, at OFC 2021, 400/800G transceivers that will enable next-generation 25.6T and 51.2T datacenter switches. The demonstration, shown in a video at II-VI's digital booth, will showcase a broad range of transceiver configurations, reaches, and form factors, each supporting the new breakthrough 100 Gbps PAM4 electrical interface compatible with next-generation 25.6T and 51.2T switch ASICs. The density of these 400/800G transceivers will enable 25.6T in a compact 1RU height.

  • 24

    Jun

  • 02

    Jul

IIVI II-VI
$69.27 /

+1.73 (+2.56%)

05/18/21
Fly Intel: Top five analyst downgrades
05/18/21 Barclays
II-VI downgraded to Equal Weight from Overweight at Barclays
05/07/21 Canaccord
II-VI price target lowered to $102 from $125 at Canaccord
05/07/21 Northland
II-VI upgraded to Outperform from Market Perform at Northland

TODAY'S FREE FLY STORIES

Earnings
Kontoor Brands reports Q2 adjusted EPS 70c, consensus 35c » 07:23
08/05/21
08/05
07:23
08/05/21
07:23
KTB

Kontoor Brands

$57.97 /

+0.485 (+0.84%)

Reports Q2 revenue $491M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KTB Kontoor Brands
$57.97 /

+0.485 (+0.84%)

KTB Kontoor Brands
$57.97 /

+0.485 (+0.84%)

07/14/21 Goldman Sachs
Kontoor Brands initiated with a Buy at Goldman Sachs
05/25/21 UBS
Kontoor Brands price target raised to $97 from $89 at UBS
05/07/21 Barclays
Kontoor Brands price target raised to $82 from $56 at Barclays
04/12/21 Piper Sandler
Kontoor Brands price target raised to $70 from $59 at Piper Sandler
KTB Kontoor Brands
$57.97 /

+0.485 (+0.84%)

KTB Kontoor Brands
$57.97 /

+0.485 (+0.84%)

Hot Stocks
Kala Pharmaceuticals sees cash funding operations for at least two years » 07:22
08/05/21
08/05
07:22
08/05/21
07:22
KALA

Kala Pharmaceuticals

$3.36 /

-0.08 (-2.33%)

As of June 30, 2021, Kala…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KALA Kala Pharmaceuticals
$3.36 /

-0.08 (-2.33%)

KALA Kala Pharmaceuticals
$3.36 /

-0.08 (-2.33%)

05/06/21 H.C. Wainwright
Kala Pharmaceuticals price target lowered to $14 from $16 at H.C. Wainwright
04/29/21
Kala Pharmaceuticals participates in a conference call hosted by Northland
04/29/21
Kala Pharmaceuticals participates in a conference call hosted by Northland
04/09/21 JPMorgan
Kala Pharmaceuticals risk/reward 'highly favorable,' says JPMorgan
KALA Kala Pharmaceuticals
$3.36 /

-0.08 (-2.33%)

KALA Kala Pharmaceuticals
$3.36 /

-0.08 (-2.33%)

Recommendations
Acadia Pharmaceuticals price target lowered to $27 from $33 at Cantor Fitzgerald » 07:22
08/05/21
08/05
07:22
08/05/21
07:22
ACAD

Acadia Pharmaceuticals

$21.05 /

-0.53 (-2.46%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACAD Acadia Pharmaceuticals
$21.05 /

-0.53 (-2.46%)

ACAD Acadia Pharmaceuticals
$21.05 /

-0.53 (-2.46%)

06/10/21 Berenberg
Berenberg starts Acadia Pharmaceuticals at Hold amid DRP uncertainty
06/10/21 Berenberg
Acadia Pharmaceuticals initiated with a Hold at Berenberg
04/07/21 Needham
Acadia price target lowered to $30 from $44 at Needham
04/07/21 H.C. Wainwright
Acadia downgraded to Neutral from Buy at H.C. Wainwright
ACAD Acadia Pharmaceuticals
$21.05 /

-0.53 (-2.46%)

ACAD Acadia Pharmaceuticals
$21.05 /

-0.53 (-2.46%)

Earnings
Cardinal Health reports Q4 EPS 77c, consensus $1.20 » 07:22
08/05/21
08/05
07:22
08/05/21
07:22
CAH

Cardinal Health

$59.01 /

-0.6 (-1.01%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CAH Cardinal Health
$59.01 /

-0.6 (-1.01%)

CAH Cardinal Health
$59.01 /

-0.6 (-1.01%)

07/20/21 Jefferies
Report of $21B opioid settlement positive for drug distributors, says Jefferies
06/07/21 Jefferies
Approval of Biogen Alzheimer's drug could be catalyst for RadNet, says Jefferies
05/10/21
Fly Intel: Top five analyst downgrades
05/10/21 Baird
Cardinal Health downgraded to Neutral from Outperform at Baird
CAH Cardinal Health
$59.01 /

-0.6 (-1.01%)

CAH Cardinal Health
$59.01 /

-0.6 (-1.01%)

CAH Cardinal Health
$59.01 /

-0.6 (-1.01%)

CAH Cardinal Health
$59.01 /

-0.6 (-1.01%)

Earnings
CareCloud reports Q2 adjusted EPS 26c, consensus (28c) » 07:22
08/05/21
08/05
07:22
08/05/21
07:22
MTBC

CareCloud

$8.65 /

+0.16 (+1.88%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MTBC CareCloud
$8.65 /

+0.16 (+1.88%)

MTBC CareCloud
$8.65 /

+0.16 (+1.88%)

06/11/21 Cantor Fitzgerald
CareCloud initiated with an Overweight at Cantor Fitzgerald
02/25/21 Roth Capital
MTBC's efforts to increase organic growth working, says Roth Capital
01/28/21
Fly Intel: Top five analyst initiations
01/28/21 Maxim
MTBC initiated with a Buy at Maxim
MTBC CareCloud
$8.65 /

+0.16 (+1.88%)

Downgrade
Nevro downgraded to Market Perform on uncertainty at William Blair » 07:22
08/05/21
08/05
07:22
08/05/21
07:22
NVRO

Nevro

$147.83 /

-3.47 (-2.29%)

William Blair analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVRO Nevro
$147.83 /

-3.47 (-2.29%)

NVRO Nevro
$147.83 /

-3.47 (-2.29%)

06:49 Today Canaccord
Nevro downgraded to Hold from Buy at Canaccord
06:10 Today JMP Securities
Nevro price target lowered to $160 from $190 at JMP Securities
06:06 Today Piper Sandler
Nevro downgraded to Neutral from Overweight at Piper Sandler
06:00 Today Citi
Nevro downgraded to Neutral from Buy at Citi
NVRO Nevro
$147.83 /

-3.47 (-2.29%)

NVRO Nevro
$147.83 /

-3.47 (-2.29%)

Recommendations
Prudential price target raised to $112 from $108 at RBC Capital » 07:22
08/05/21
08/05
07:22
08/05/21
07:22
PRU

Prudential

$99.88 /

-2.29 (-2.24%)

RBC Capital analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRU Prudential
$99.88 /

-2.29 (-2.24%)

PRU Prudential
$99.88 /

-2.29 (-2.24%)

05/06/21 RBC Capital
Prudential price target raised to $108 from $92 at RBC Capital
04/20/21 UBS
Prudential initiated with a Neutral at UBS
04/15/21 Credit Suisse
Prudential upgraded to Outperform from Neutral at Credit Suisse
04/12/21 Barclays
Prudential price target raised to $96 from $91 at Barclays
PRU Prudential
$99.88 /

-2.29 (-2.24%)

PRU Prudential
$99.88 /

-2.29 (-2.24%)

Earnings
Kala Pharmaceuticals reports Q2 EPS (57c), consensus (45c) » 07:22
08/05/21
08/05
07:22
08/05/21
07:22
KALA

Kala Pharmaceuticals

$3.36 /

-0.08 (-2.33%)

Reports Q2 revenues…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KALA Kala Pharmaceuticals
$3.36 /

-0.08 (-2.33%)

KALA Kala Pharmaceuticals
$3.36 /

-0.08 (-2.33%)

05/06/21 H.C. Wainwright
Kala Pharmaceuticals price target lowered to $14 from $16 at H.C. Wainwright
04/29/21
Kala Pharmaceuticals participates in a conference call hosted by Northland
04/29/21
Kala Pharmaceuticals participates in a conference call hosted by Northland
04/09/21 JPMorgan
Kala Pharmaceuticals risk/reward 'highly favorable,' says JPMorgan
KALA Kala Pharmaceuticals
$3.36 /

-0.08 (-2.33%)

KALA Kala Pharmaceuticals
$3.36 /

-0.08 (-2.33%)

Earnings
Berry Global reports Q3 EPS $1.53, consensus $1.51 » 07:21
08/05/21
08/05
07:21
08/05/21
07:21
BERY

Berry Global

$63.74 /

-1.49 (-2.28%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BERY Berry Global
$63.74 /

-1.49 (-2.28%)

BERY Berry Global
$63.74 /

-1.49 (-2.28%)

05/21/21 BMO Capital
Berry Global price target raised to $82 from $78 at BMO Capital
05/05/21 Wells Fargo
Berry Global price target raised to $80 from $72 at Wells Fargo
05/05/21 Deutsche Bank
Berry Global price target raised to $78 from $70 at Deutsche Bank
04/15/21 Jefferies
Berry Global price target raised to $73 from $70 at Jefferies
BERY Berry Global
$63.74 /

-1.49 (-2.28%)

BERY Berry Global
$63.74 /

-1.49 (-2.28%)

Earnings
Scorpio Tankers reports Q2 adjusted EPS (94c), consensus (64c) » 07:20
08/05/21
08/05
07:20
08/05/21
07:20
STNG

Scorpio Tankers

$15.34 /

-0.85 (-5.25%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STNG Scorpio Tankers
$15.34 /

-0.85 (-5.25%)

STNG Scorpio Tankers
$15.34 /

-0.85 (-5.25%)

07/23/21 H.C. Wainwright
Scorpio Tankers weakness brings buying opportunity, says H.C. Wainwright
03/29/21 H.C. Wainwright
Scorpio Tankers initiated with a Buy at H.C. Wainwright
03/19/21 BTIG
Scorpio Tankers price target raised to $28 from $25 at BTIG
02/19/21 B. Riley Securities
Scorpio Tankers price target lowered to $35 from $40 at B. Riley Securities
STNG Scorpio Tankers
$15.34 /

-0.85 (-5.25%)

STNG Scorpio Tankers
$15.34 /

-0.85 (-5.25%)

Hot Stocks
BioCryst expects cash runway into 2023 » 07:20
08/05/21
08/05
07:20
08/05/21
07:20
BCRX

BioCryst

$16.31 /

-0.425 (-2.54%)

In the launch period for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BCRX BioCryst
$16.31 /

-0.425 (-2.54%)

BCRX BioCryst
$16.31 /

-0.425 (-2.54%)

08/03/21 Cantor Fitzgerald
BioCryst initiated with an Overweight at Cantor Fitzgerald
08/03/21 Cantor Fitzgerald
BioCryst initiated with an Overweight at Cantor Fitzgerald
06/17/21 Cowen
BioCryst price target raised to $21 from $18 at Cowen
05/28/21 Piper Sandler
BioCryst price target raised to $18 from $15 at Piper Sandler
BCRX BioCryst
$16.31 /

-0.425 (-2.54%)

BCRX BioCryst
$16.31 /

-0.425 (-2.54%)

BCRX BioCryst
$16.31 /

-0.425 (-2.54%)

Earnings
Huntington Ingalls reports Q2 adjusted EPS $3.05, consensus $2.49 » 07:20
08/05/21
08/05
07:20
08/05/21
07:20
HII

Huntington Ingalls

$200.42 /

-3.59 (-1.76%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HII Huntington Ingalls
$200.42 /

-3.59 (-1.76%)

HII Huntington Ingalls
$200.42 /

-3.59 (-1.76%)

05/10/21 Bernstein
Huntington Ingalls price target raised to $229 from $193 at Bernstein
01/06/21 Vertical Research
Huntington Ingalls downgraded to Hold from Buy at Vertical Research
12/04/20 Alembic Global
Huntington Ingalls upgraded to Overweight from Neutral at Alembic Global
10/02/20 JPMorgan
Huntington Ingalls price target lowered to $175 from $205 at JPMorgan
HII Huntington Ingalls
$200.42 /

-3.59 (-1.76%)

HII Huntington Ingalls
$200.42 /

-3.59 (-1.76%)

Recommendations
Spirit AeroSystems price target lowered to $54 from $60 at Susquehanna » 07:19
08/05/21
08/05
07:19
08/05/21
07:19
SPR

Spirit AeroSystems

$40.48 /

-2.735 (-6.33%)

Susquehanna analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPR Spirit AeroSystems
$40.48 /

-2.735 (-6.33%)

SPR Spirit AeroSystems
$40.48 /

-2.735 (-6.33%)

06/23/21 Susquehanna
Spirit AeroSystems estimates raised as demand strengthens, says Susquehanna
06/22/21 Cowen
Spirit AeroSystems price target raised to $70 from $60 at Cowen
03/15/21 Morgan Stanley
Aerospace sector upgraded to Attractive from Cautious at Morgan Stanley
03/15/21 Morgan Stanley
Spirit AeroSystems price target raised to $54 from $50 at Morgan Stanley
SPR Spirit AeroSystems
$40.48 /

-2.735 (-6.33%)

SPR Spirit AeroSystems
$40.48 /

-2.735 (-6.33%)

Earnings
Adient reports Q3 adjusted EPS (53c), consensus 22c » 07:19
08/05/21
08/05
07:19
08/05/21
07:19
ADNT

Adient

$39.78 /

-1.45 (-3.52%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADNT Adient
$39.78 /

-1.45 (-3.52%)

ADNT Adient
$39.78 /

-1.45 (-3.52%)

07/15/21 Deutsche Bank
Adient price target lowered to $57 from $63 at Deutsche Bank
05/13/21 Morgan Stanley
Adient price target raised to $40 from $38 at Morgan Stanley
05/07/21 Deutsche Bank
Adient price target raised to $63 from $58 at Deutsche Bank
03/25/21 Wells Fargo
Adient initiated with an Overweight at Wells Fargo
ADNT Adient
$39.78 /

-1.45 (-3.52%)

ADNT Adient
$39.78 /

-1.45 (-3.52%)

ADNT Adient
$39.78 /

-1.45 (-3.52%)

Earnings
BioCryst reports Q2 EPS (24c), consensus (24c) » 07:19
08/05/21
08/05
07:19
08/05/21
07:19
BCRX

BioCryst

$16.31 /

-0.425 (-2.54%)

Reports Q2 revenue $50M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BCRX BioCryst
$16.31 /

-0.425 (-2.54%)

BCRX BioCryst
$16.31 /

-0.425 (-2.54%)

08/03/21 Cantor Fitzgerald
BioCryst initiated with an Overweight at Cantor Fitzgerald
08/03/21 Cantor Fitzgerald
BioCryst initiated with an Overweight at Cantor Fitzgerald
06/17/21 Cowen
BioCryst price target raised to $21 from $18 at Cowen
05/28/21 Piper Sandler
BioCryst price target raised to $18 from $15 at Piper Sandler
BCRX BioCryst
$16.31 /

-0.425 (-2.54%)

BCRX BioCryst
$16.31 /

-0.425 (-2.54%)

BCRX BioCryst
$16.31 /

-0.425 (-2.54%)

Hot Stocks
Athenex expects cash, cash equivalents to fund operations into Q4 of 2022 » 07:19
08/05/21
08/05
07:19
08/05/21
07:19
ATNX

Athenex

$3.70 /

-0.11 (-2.89%)

As of June 30, 2021, the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATNX Athenex
$3.70 /

-0.11 (-2.89%)

ATNX Athenex
$3.70 /

-0.11 (-2.89%)

03/02/21
Fly Intel: Top five analyst downgrades
03/02/21 SVB Leerink
Athenex downgraded to Market Perform from Outperform at SVB Leerink
03/02/21 Oppenheimer
Athenex downgraded to Perform from Outperform at Oppenheimer
03/02/21 Truist
Athenex downgraded to Hold from Buy at Truist
ATNX Athenex
$3.70 /

-0.11 (-2.89%)

  • 10
    Sep
ATNX Athenex
$3.70 /

-0.11 (-2.89%)

ATNX Athenex
$3.70 /

-0.11 (-2.89%)

Earnings
Terminix sees FY21 revenue $2.03B- $2.1B consensus $2.04B  07:19
08/05/21
08/05
07:19
08/05/21
07:19
TMX

Terminix

$51.56 /

-0.05 (-0.10%)

 
ShowHide Related Items >><<
TMX Terminix
$51.56 /

-0.05 (-0.10%)

TMX Terminix
$51.56 /

-0.05 (-0.10%)

11/06/20 Baird
Terminix upgraded to Outperform at Baird
11/06/20 Baird
Terminix upgraded to Outperform from Neutral at Baird
10/16/20 Stifel
Terminix added to Select List at Stifel
TMX Terminix
$51.56 /

-0.05 (-0.10%)

Downgrade
Advanced Energy downgraded to Hold from Buy at Needham » 07:19
08/05/21
08/05
07:19
08/05/21
07:19
AEIS

Advanced Energy

$90.28 /

-12.27 (-11.96%)

Needham analyst Quinn…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AEIS Advanced Energy
$90.28 /

-12.27 (-11.96%)

AEIS Advanced Energy
$90.28 /

-12.27 (-11.96%)

07:16 Today Susquehanna
Advanced Energy price target lowered to $112 from $125 at Susquehanna
06:29 Today Citi
Advanced Energy price target lowered to $100 from $110 at Citi
04/21/21 Needham
Advanced Energy price target raised to $135 from $128 at Needham
02/11/21 Citi
Advanced Energy price target lowered to $120 from $130 at Citi
AEIS Advanced Energy
$90.28 /

-12.27 (-11.96%)

AEIS Advanced Energy
$90.28 /

-12.27 (-11.96%)

Earnings
Athenex reports Q2 EPS (33c), consensus (37c) » 07:18
08/05/21
08/05
07:18
08/05/21
07:18
ATNX

Athenex

$3.70 /

-0.11 (-2.89%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATNX Athenex
$3.70 /

-0.11 (-2.89%)

ATNX Athenex
$3.70 /

-0.11 (-2.89%)

03/02/21
Fly Intel: Top five analyst downgrades
03/02/21 SVB Leerink
Athenex downgraded to Market Perform from Outperform at SVB Leerink
03/02/21 Oppenheimer
Athenex downgraded to Perform from Outperform at Oppenheimer
03/02/21 Truist
Athenex downgraded to Hold from Buy at Truist
ATNX Athenex
$3.70 /

-0.11 (-2.89%)

  • 10
    Sep
ATNX Athenex
$3.70 /

-0.11 (-2.89%)

ATNX Athenex
$3.70 /

-0.11 (-2.89%)

Recommendations
Booking Holdings price target raised to $2,450 from $2,400 at Stifel » 07:18
08/05/21
08/05
07:18
08/05/21
07:18
BKNG

Booking Holdings

$2,088.46 /

-53.68 (-2.51%)

Stifel analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BKNG Booking Holdings
$2,088.46 /

-53.68 (-2.51%)

BKNG Booking Holdings
$2,088.46 /

-53.68 (-2.51%)

04:55 Today Piper Sandler
Booking Holdings price target raised to $2,375 from $2,345 at Piper Sandler
05/26/21 RBC Capital
Booking Holdings assumed with a Sector Perform at RBC Capital
05/07/21 Susquehanna
Booking Holdings price target lowered to $2850 from $3000 at Susquehanna
05/06/21 Credit Suisse
Booking Holdings price target lowered to $2,675 from $2,740 at Credit Suisse
BKNG Booking Holdings
$2,088.46 /

-53.68 (-2.51%)

BKNG Booking Holdings
$2,088.46 /

-53.68 (-2.51%)

BKNG Booking Holdings
$2,088.46 /

-53.68 (-2.51%)

Recommendations
Alibaba price target lowered to $310 from $350 at Susquehanna » 07:18
08/05/21
08/05
07:18
08/05/21
07:18
BABA

Alibaba

/

+

Susquehanna analyst Shyam…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BABA Alibaba
/

+

BABA Alibaba
/

+

08/04/21 KeyBanc
Alibaba price target lowered to $250 from $270 at KeyBanc
08/04/21 Benchmark
Alibaba price target lowered to $277 from $282 at Benchmark
08/04/21 Oppenheimer
Alibaba price target lowered to $300 from $310 at Oppenheimer
08/04/21 UBS
Alibaba price target lowered to $260 from $280 at UBS
BABA Alibaba
/

+

BABA Alibaba
/

+

BABA Alibaba
/

+

BABA Alibaba
/

+

Downgrade
AtriCure downgraded to Perform from Outperform at Oppenheimer » 07:18
08/05/21
08/05
07:18
08/05/21
07:18
ATRC

AtriCure

$81.95 /

-1.62 (-1.94%)

Oppenheimer analyst Suraj…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATRC AtriCure
$81.95 /

-1.62 (-1.94%)

ATRC AtriCure
$81.95 /

-1.62 (-1.94%)

04:53 Today Piper Sandler
AtriCure should be bought on weakness from aMAZE update, says Piper Sandler
06/15/21 Stifel
AtriCure price target raised to $85 from $72 at Stifel
05/26/21 SVB Leerink
AtriCure price target raised to $95 from $78 at SVB Leerink
05/14/21 JPMorgan
AtriCure price target raised to $81 from $70 at JPMorgan
ATRC AtriCure
$81.95 /

-1.62 (-1.94%)

ATRC AtriCure
$81.95 /

-1.62 (-1.94%)

Earnings
Maximus raises FY21 EPS view to $4.65-$4.75 from $4.20-$4.40, consensus $4.33 » 07:17
08/05/21
08/05
07:17
08/05/21
07:17
MMS

Maximus

$86.06 /

-1.49 (-1.70%)

Raises FY21 revenue view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MMS Maximus
$86.06 /

-1.49 (-1.70%)

MMS Maximus
$86.06 /

-1.49 (-1.70%)

06/28/21
Fly Intel: Top five analyst downgrades
06/28/21 Raymond James
Maximus downgraded to Outperform from Strong Buy at Raymond James
04/22/21 Canaccord
Maximus price target raised to $95 from $79 at Canaccord
MMS Maximus
$86.06 /

-1.49 (-1.70%)

MMS Maximus
$86.06 /

-1.49 (-1.70%)

Earnings
Harvard Bioscience sees 2021 revenue growth 12%-15% vs. 2020  07:17
08/05/21
08/05
07:17
08/05/21
07:17
HBIO

Harvard Bioscience

$8.18 /

-0.09 (-1.09%)

Consensus $115.29M.

ShowHide Related Items >><<
HBIO Harvard Bioscience
$8.18 /

-0.09 (-1.09%)

03/10/21 KeyBanc
Harvard Bioscience price target raised to $9 from $6 at KeyBanc
01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
12/09/20 Northland
Harvard Bioscience initiated with an Outperform at Northland
11/09/20 KeyBanc
Harvard Bioscience initiated with an Overweight at KeyBanc
HBIO Harvard Bioscience
$8.18 /

-0.09 (-1.09%)

Hot Stocks
BCE reaffirms FY21 guidance given on February 4  07:17
08/05/21
08/05
07:17
08/05/21
07:17
BCE

BCE

$49.72 /

-0.19 (-0.38%)

 
ShowHide Related Items >><<
BCE BCE
$49.72 /

-0.19 (-0.38%)

BCE BCE
$49.72 /

-0.19 (-0.38%)

08/04/21 TD Securities
BCE price target raised to C$66 from C$63 at TD Securities
05/03/21 Desjardins
BCE price target raised to C$62 from C$61 at Desjardins
04/30/21 Canaccord
BCE price target raised to C$59 from C$58 at Canaccord
04/30/21 RBC Capital
BCE price target raised to C$60 from C$59 at RBC Capital
BCE BCE
$49.72 /

-0.19 (-0.38%)

BCE BCE
$49.72 /

-0.19 (-0.38%)

BCE BCE
$49.72 /

-0.19 (-0.38%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.